Moy, R.H., Gold, B., Molleston, J.M., Schad, V., Yanger, K., Salzano, M.V., Yagi, Y., Fitzgerald, K.A., Stanger, B.Z., Soldan, S.S., Cherry, S. (2014). Antiviral autophagy restricts rift valley Fever virus infection and is conserved from flies to mammals.  Immunity 40(1): 51--65.

FBrf0223846

Research paper

Autophagy has been implicated as a component of host defense, but the significance of antimicrobial autophagy in vivo and the mechanism by which it is regulated during infection are poorly defined. Here we found that antiviral autophagy was conserved in flies and mammals during infection with Rift Valley fever virus (RVFV), a mosquito-borne virus that causes disease in humans and livestock. In Drosophila, Toll-7 limited RVFV replication and mortality through activation of autophagy. RVFV infection also elicited autophagy in mouse and human cells, and viral replication was increased in the absence of autophagy genes. The mammalian Toll-like receptor adaptor, MyD88, was required for anti-RVFV autophagy, revealing an evolutionarily conserved requirement for pattern-recognition receptors in antiviral autophagy. Pharmacologic activation of autophagy inhibited RVFV infection in mammalian cells, including primary hepatocytes and neurons. Thus, autophagy modulation might be an effective strategy for treating RVFV infection, which lacks approved vaccines and therapeutics.

PMC3951734 (PMC) (EuropePMC)